Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
January 2011

Depression, Inflammation, and Statins
In patients who have had a recent cardiac event, statins are associated with a significant reduction in the risk of depression.

Treating BDD
Although body dysmorphic disorder is difficult to treat, serotonin reuptake inhibitors and cognitive behavioral therapy may improve symptoms.

Measurement-Enhanced Care
A measurement-enhanced care approach to psychiatry, in which symptoms are measured before and during treatment, is seldom used in clinical practice but may become more common in the future.

In Brief
Children with ADHD Have More Chromosomal Structural Abnormalities; Medicare/Medicaid Prescription Plan Switch Associated with Increases in Suicidal Ideation and Behavior

SRIs and Thinning Bone
Highly serotonergic agents may adversely affect bone density.

Stimulants in Dementia
Methylphenidate (Ritalin and others) may provide relief for apathy in patients with dementia but with the risk of adverse cardiovascular and behavioral effects.

Treating BDD

January 2011

Approximately 1% to 2% of the population has body dysmorphic disorder (BDD), an illness that can have profound effects on functioning and quality of life.1 Typically beginning in early adolescence, BDD consists of preoccupation with an imagined or slight defect in appearance, which causes…

To view the rest of this article, please: